Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LPAR3 | Q9UBY5 | 10/20 | 0.49 |
| ▸ | LPAR2 | Q9HBW0 | 6/20 | 0.49 |
| ▸ | LPAR1 | Q92633 | 5/20 | 0.49 |
| ▸ | AKT1 | P31749 | 3/20 | 0.47 |
| ▸ | MAPK14 | Q16539 | 2/20 | 0.47 |
| ▸ | TERT | O14746 | 1/20 | 0.47 |
| ▸ | UCHL3 | P15374 | 1/20 | 0.47 |
| ▸ | NAAA | Q02083 | 2/20 | 0.44 |
| ▸ | PLCG2 | P16885 | 1/20 | 0.41 |
| ▸ | PIK3R1 | P27986 | 1/20 | 0.41 |
| ▸ | AKT2 | P31751 | 1/20 | 0.41 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.41 |
| ▸ | AKT3 | Q9Y243 | 1/20 | 0.41 |
| ▸ | GAB1 | Q13480 | 1/20 | 0.41 |
| ▸ | LPAR5 | Q9H1C0 | 1/20 | 0.39 |
| ▸ | ACHE | P22303 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10534538 | 0.98 | LPAR3 (0.51) | LPAR3LPAR2LPAR1AKT1MAPK14 | |
| SCHEMBL14468696 | 0.98 | LPAR3 (0.51) | LPAR3LPAR2LPAR1AKT1MAPK14 | |
| SCHEMBL10781111 | 0.98 | LPAR3 (0.51) | LPAR3LPAR2LPAR1AKT1MAPK14 | |
| SCHEMBL8657356 | 0.98 | LPAR3 (0.51) | LPAR3LPAR2LPAR1AKT1MAPK14 | |
| SCHEMBL8657287 | 0.97 | LPAR3 (0.53) | LPAR3LPAR2LPAR1AKT1MAPK14 | |
| SCHEMBL17169188 | 0.95 | CYP3A4 (0.42) | LPAR3LPAR2LPAR1AKT1MAPK14 | |
| SCHEMBL28897807 | 0.88 | ACHE (0.42) | LPAR3LPAR2LPAR1AKT1MAPK14 | |
| SCHEMBL29001726 | 0.86 | ACHE (0.39) | LPAR3LPAR2LPAR1AKT1MAPK14 | |
| SCHEMBL14448095 | 0.84 | AKT1 (0.52) | LPAR3LPAR2LPAR1AKT1MAPK14 | |
| SCHEMBL14491950 | 0.83 | LPAR3 (0.43) | LPAR3LPAR2LPAR1AKT1MAPK14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180057870-A1 | TAGGED NUCLEOTIDES USEFUL FOR NANOPORE DETECTION | Roche Sequencing Solutions, Inc. | 2018-03-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180057870-A1 | TAGGED NUCLEOTIDES USEFUL FOR NANOPORE DETECTION | PHAX, POLRMT, POLN | LPAR3 3474/4885LPAR2 3499/4885LPAR1 3376/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.